Author:
Andreieva S. V.,Korets K. V.,Tsyapka O. M.,Skorokhod I. M.
Reference33 articles.
1. Abdulwahab, A., Sykes, J., Kamel-Reid, S., et al., Therapy-related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosis, Cancer, 2012, vol. 118, no. 16, pp. 3962–3967. https://doi.org/10.1002/cncr.26735
2. Aldoss, I., Douer, D., and Pullarkat, V., Acute lymphoblastic leukemia in the older adult, J. Oncol. Pract., 2019, vol. 15, no. 2, pp. 67–75. https://doi.org/10.1200/JOP.18.00271
3. Atlas of Genetics and Cytogenetics in Oncology and Haematology, Inst. Biomed. Res. of Salamanca, 2022. https://atlasgeneticsoncology.org.
4. Aubrey, B., Strasser, A., and Kelly, G., Tumor-supressor functions of the TP53 pathway, Cold Spring Harbor Perspect. Med., 2016, vol. 6, no. 5, p. a026062. https://doi.org/10.1101/cshperspect.a026062
5. Bach, D., Zhang, W., and Sood, A., Chromosomal instability in tumor initiation and development, Cancer Res., 2019, vol. 79, no. 16, pp. 3995–4002. https://doi.org/10.1158/0008-5472.CAN-18-3235